Drug Pipeline

Induction Chemotherapy Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
3
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-20 NCT00602667
Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus…		 date change Completion pushed: 2026-04 -> 2029-04
Active Studies by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07564453 Full-course Immunotherapy Combined With Chemotherapy in Newly Diagnosed B-cell Acute… B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Recruiting
NCT07259473 Factors Influencing Immunotherapy Response in dMMR/MSI-H Gastric/Gastroesophageal… Gastric / Gastroesophageal Junction Adenocarcinoma Not Yet Recruiting
NCT00602667 Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus… Brain and Central Nervous System Tumors Active, Not Recruiting
Sponsors Running Induction Chemotherapy Trials
St. Jude Children's Research Hospital (1) Shanghai Zhongshan Hospital (1) The First Affiliated Hospital of Soochow University (1)
Disease Areas
Leukemia (1) Acute Lymphoblastic Leukemia (ALL) (1)
Get alerts when Induction Chemotherapy trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free